MLYS - Mineralys Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Mineralys Therapeutics, Inc.
IPO Date: February 10, 2023
Sector: Healthcare
Industry: Biotech
Market Cap: $1.95B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.56 | 3.23%
Avg Daily Range (30 D): $0.78 | 2.90%
Avg Daily Range (90 D): $0.72 | 2.70%
Institutional Daily Volume
Avg Daily Volume: .58M
Avg Daily Volume (30 D): 1.08M
Avg Daily Volume (90 D): 1.08M
Trade Size
Avg Trade Size (Sh.): 67
Avg Trade Size (Sh.) (30 D): 65
Avg Trade Size (Sh.) (90 D): 68
Institutional Trades
Total Institutional Trades: 1,229
Avg Institutional Trade: $2.59M
Avg Institutional Trade (30 D): $3.11M
Avg Institutional Trade (90 D): $3.09M
Avg Institutional Trade Volume: .1M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.54M
Avg Closing Trade (30 D): $6.68M
Avg Closing Trade (90 D): $5.9M
Avg Closing Volume: 173.3K
 
News
Oct 2, 2026 @ 8:30 PM
Mineralys Therapeutics Announces Presentation of N...
Source: Mineralys Therapeutics, Inc.
Sep 16, 2026 @ 5:00 PM
Hypertension Clinical Trial Pipeline Accelerates a...
Source: Delveinsight
Jun 8, 2026 @ 11:00 AM
Mineralys Therapeutics to Present Late-Breaking Da...
Source: Na
Jun 3, 2026 @ 10:00 AM
Mineralys Therapeutics Announces Repurchase of Roy...
Source: Na
May 31, 2026 @ 2:19 PM
Velan Capital Drops 140,000 Mineralys Therapeutics...
Source: Cory Renauer
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-4.19 $-2.85 $-.47
Diluted EPS $-4.19 $-2.85 $-.47
Revenue $M $M $M
Gross Profit
Net Income / Loss $-349.58M $-241.07M $-39.34M
Operating Income / Loss $-370.79M $-246.04M $-45.34M
Cost of Revenue
Net Cash Flow $36.48M $25.49M $-60.14M
PE Ratio